PA2G4 and prostate carcinoma: EBP1 is also distinctly expressed in various kinds of cancers, such as bladder cancer [24], glioblastoma [25], non-small cell lung carcinoma (NSCLC) [26], cervical cancer [27], acute myeloid leukemia (AML) [28], salivary adenoid cystic carcinoma [29], colon cancer [30] and prostate cancer [31,32].